Arch Biopartners announced a non-brokered private placement of 1,058,823 shares at $0.85 each, raising $900,000 CAD. The funds will support onboarding U.S. clinical sites for their Phase II trial of the LSALT peptide targeting acute kidney injury related to cardiac surgery, accelerate pre-clinical studies for chronic kidney disease treatments, and cover general operating costs. The offering includes shares issued to a company officer and is subject to regulatory approvals, with settlement expected around November 12, 2026. This financing move supports Arch's ongoing efforts to develop treatments for acute and chronic kidney diseases affecting millions globally.
Arch Biopartners' recent private placement is noted here alongside Pluang's health sector market snapshot. For readers following health stocks, as of Nov 06, 2026 18:31 WIB, out of 150 priced US health-sector stocks tradable on Pluang, 47 rose and 94 fell. Notable movers include TMDX at USD 77.14 with a 1-day change of +11.83% and 100% buy order activity, XRAY at USD 9.00 down 10.80%, and GMED at USD 74.08 down 9.13% with 100% buy order activity and a typical hold time of 13 days.
Nexans has signed a subcontract to deliver a 420 km mass-impregnated 110 kV cable system for the 1 GW, 320 kV Corinth-Kos HVDC interconnection in Greece. This project, awarded to Hellenic Cables and partners, will connect the Dodecanese islands to ma...
Guggenheim analyst Howard Ma raised JFrog's price target to $125, signaling a 67.5% potential upside from its current price of $74.62. JFrog reported strong Q3 2026 results with revenue up 31% year-over-year to $179.2 million, driven by a 60% surge i...
The Indonesia data center market is projected to grow from USD 2.08 billion in 2027 to USD 4.05 billion by 2032, at a CAGR of 14.28%. Growth is fueled by expanding hyperscaler cloud infrastructure, rising digital workloads, increasing demand for colo...
Tesla and SpaceX, Elon Musk's two largest public companies, lost a combined $457 billion in market value between November 3 and 5, 2026, following Democratic wins in Congress and key Texas races. Tesla's stock dropped nearly 14%, while SpaceX fell ov...
TeraWulf announced $76.2 million in revenue for Q3 2026, with high-performance computing leases contributing about 83% ($63 million) of that total. The company reaffirmed its fiscal 2026 goal to add 250 to 500 megawatts of critical IT capacity annual...
